Ownership history in Lindbrook Capital, LLC · 8 quarters on record
This page tracks every 13F SEC filing in which Lindbrook Capital, LLC reported a position in HEALTH CATALYST INC COM (HCAT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2024 Q4 | UNCHANGED | 113 | — | 0% | 0.00% | $799 | $7.07 |
| 2024 Q3 | REDUCED | 113 | -303 | -72.8% | 0.00% | $920 | $8.14 |
| 2023 Q3 | UNCHANGED | 416 | — | 0% | 0.00% | $4K | $10.12 |
| 2023 Q2 | REDUCED | 416 | -145 | -25.8% | 0.00% | $5K | $12.50 |
| 2023 Q1 | REDUCED | 561 | -57 | -9.2% | 0.00% | $7K | $11.67 |
| 2022 Q4 | ADDED | 618 | +388 | +168.7% | 0.00% | $7K | $10.63 |
| 2022 Q3 | ADDED | 230 | +102 | +79.7% | 0.00% | $2K | $9.70 |
| 2022 Q2 | INITIATED | 128 | — | — | 0.00% | $2K | $14.49 |
As of 2025 Q4 — sorted by position size